Medical Devices Sector Reports

psss. want annual reports you can read in 30 seconds?
Medinotec Inc.
Filing Date: 2024-07-12
TL;DR
  • 📈 Revenue Growth: Revenue jumped to $2.3 million from $416k last year.
  • 💡 Innovative Devices: Launched new tracheal dilation and cardiology products.
  • 🌍 Market Expansion: Increased sales in South Africa and the USA.
  • 🌿 Sustainability: Focused on sustainable practices and reducing environmental impact.
Major Announcements

Significant announcements included new distribution agreements in the cardiology sector and the expansion of their product lineup with innovative medical devices.
ENCISION INC
Filing Date: 2024-07-15
TL;DR
  • 💡 Innovative Tech: Patented AEM technology for safer surgeries.
  • 📉 Revenue Dip: Revenue decreased by 7% in 2024.
  • 🌍 Market Expansion: Growing presence in international markets.
  • 🌿 Sustainability: Focused on reducing hospital waste with reusable products.
Major Announcements

Encision announced a new Proof-of-Concept Services Agreement with Vicarious Surgical Inc. to integrate their AEM technology into robotic-assisted surgeries. They also received a Vizient Innovative Technology Contract, increasing their visibility in the healthcare market.
INTUITIVE SURGICAL INC
Filing Date: 2024-07-19
TL;DR
  • 🤖 Innovative Products: Launched new da Vinci 5 surgical system.
  • 📈 Strong Revenue: Total revenue of $3.9 billion for the first half of 2024.
  • 🌍 Market Expansion: Focus on growing in emerging markets like China and South Korea.
  • 🌿 Sustainability Goals: Committed to reducing environmental impact and promoting sustainability.
Major Announcements

Significant announcements in 2024 include the FDA clearance of the da Vinci 5 surgical system and the regulatory approval of the Ion endoluminal system in China. These milestones highlight the company's commitment to innovation and expanding its product portfolio.
Autonomix Medical, Inc.
Filing Date: 2024-07-26
TL;DR
  • 📉 Revenue Drop: Faced a decline in revenue due to increased competition.
  • 💡 New Leadership: Appointed new CEO Brad Hauser in June 2024.
  • 🌍 Market Expansion: Targeting emerging markets with new strategies.
  • 🌱 Sustainability Efforts: Committed to using more recycled materials.
Major Announcements

Major announcements in 2024 included the appointment of Brad Hauser as CEO and new strategic partnerships in the healthcare sector. These moves are aimed at strengthening the company's market position and driving innovation.
DEXCOM INC
Filing Date: 2024-07-25
TL;DR
  • 📈 Strong Growth: Revenue increased by 19% to $1.93 billion.
  • 💡 New Products: Launched Dexcom G7 and Stelo, a non-prescription glucose biosensor.
  • 🌍 Global Expansion: Focus on growing international markets.
  • 🌿 Sustainability: Committed to reducing carbon footprint.
Major Announcements

DexCom announced the launch of the Dexcom G7 and Stelo, and new partnerships in the healthcare sector to expand their product reach and impact.
ZYNEX INC
Filing Date: 2024-07-25
TL;DR
  • 📈 Revenue Growth: Revenue increased by 11% to $96.4 million for the first half of 2024.
  • 💡 New Devices: Launched new electrotherapy products and continued development of monitoring solutions.
  • 🌍 Market Focus: All revenue generated in North America.
  • 🌿 Sustainability: Committed to reducing environmental impact through efficient manufacturing processes.
Major Announcements

Zynex announced the release of new electrotherapy devices and continued progress in the development of their laser-based monitoring systems. They also reported significant investments in expanding their manufacturing capabilities.
EKSO BIONICS HOLDINGS, INC.
Filing Date: 2024-07-29
TL;DR
  • 📉 Financial Struggles: Revenue of $8.7 million, but a net loss of $5.8 million.
  • 🦾 Innovative Tech: Focus on exoskeletons for medical and industrial use.
  • 🌍 Market Expansion: Growing presence in Europe and Asia.
  • 💚 Sustainability: Committed to reducing environmental impact.
Major Announcements

Ekso Bionics announced a new partnership with Parker Hannifin Corporation to enhance their product offerings and a significant investment in research and development to improve their exoskeleton technology.
INTEGRA LIFESCIENCES HOLDINGS CORP
Filing Date: 2024-07-29
TL;DR
  • 📉 Revenue Dip: Revenue was $787 million, slightly up from last year.
  • 💼 Acquisition: Acquired Acclarent, enhancing their ENT product line.
  • 🌱 Sustainability: Focused on reducing environmental impact.
  • 🔮 Future Plans: Aiming for growth in new markets and product lines.
Major Announcements

Significant announcements in 2024 included the acquisition of Acclarent, which added new ENT products to their portfolio. They also announced plans to transition production from their Boston facility to Braintree, Massachusetts, to improve manufacturing efficiency.
AtriCure, Inc.
Filing Date: 2024-07-31
TL;DR
  • 📈 Strong Growth: Revenue increased by 15.8% to $225.1 million in the first half of 2024.
  • 💡 New Products: Launched cryoSPHERE®+ for pain management and received regulatory approvals.
  • 🌍 Global Expansion: Increased sales in international markets by 25.6%.
  • 🌿 Sustainability: Committed to reducing environmental impact and promoting sustainable practices.
Major Announcements

Significant announcements in 2024 include regulatory approvals for new products in China and the US, and the launch of new training programs for healthcare professionals.
Penumbra Inc
Filing Date: 2024-07-30
TL;DR
  • 💰 Strong Revenue: Penumbra's revenue increased significantly.
  • 🩺 New Products: Introduced innovative medical devices.
  • 🌍 Market Expansion: Focused on growing in new regions.
  • 🌿 Sustainability: Committed to eco-friendly practices.
Major Announcements

Penumbra made significant announcements about new partnerships in the healthcare sector and investments in research and development to drive future innovation.
SURMODICS INC
Filing Date: 2024-07-31
TL;DR
  • 📉 Revenue Drop: Revenue decreased by 42% in the last quarter.
  • 💡 New Products: Launched new thrombectomy and radial access devices.
  • 🌍 Market Expansion: Focus on global distribution through partnerships.
  • 🌿 Sustainability Goals: Committed to reducing environmental impact.
Major Announcements

Surmodics announced a merger agreement with BCE Parent, LLC, which will acquire Surmodics for $43.00 per share. This merger aims to enhance the company's market position and financial stability.
TELEFLEX INC
Filing Date: 2024-08-02
TL;DR
  • 📈 Strong Financials: Good revenue and profit growth.
  • 💡 Innovative Products: New medical devices launched.
  • 🌍 Market Expansion: Growing in new markets.
  • 🌿 Sustainability Goals: Focus on being eco-friendly.
Major Announcements

Teleflex announced several major initiatives in 2024, including partnerships with leading hospitals for clinical trials and investments in new manufacturing facilities. They also launched a new corporate social responsibility program focused on community health.
PROCEPT BioRobotics Corp
Filing Date: 2024-08-02
TL;DR
  • 🤖 Innovative Tech: Advanced surgical robots for treating prostate diseases.
  • 📈 Growing Revenue: Significant increase in revenue and system installations.
  • 🌍 Market Expansion: Focus on increasing presence in U.S. hospitals.
  • 🌿 Sustainability: Committed to reducing environmental impact.
Major Announcements

Significant announcements included receiving FDA clearance to expand the use of their AquaBeam Robotic System to patients with an active diagnosis of prostate cancer. This regulatory milestone is expected to broaden the system's application and market reach.
Sight Sciences, Inc.
Filing Date: 2024-08-02
TL;DR
  • 📉 Revenue Drop: Total revenue decreased by 3.9% compared to last year.
  • 💡 New Products: Continued focus on innovative glaucoma and dry eye treatments.
  • 🌍 Market Expansion: Growing presence in the U.S. and Europe.
  • 🌿 Sustainability Goals: Committed to reducing environmental impact.
Major Announcements

Major announcements in 2024 included new clinical trial results demonstrating the effectiveness of their products and strategic partnerships to expand their market reach.They also announced initiatives to improve insurance coverage for their dry eye treatments.
CVRx, Inc.
Filing Date: 2024-08-02
TL;DR
  • 💸 Revenue Growth: Revenue increased by 29% to $22.6 million.
  • 📊 Operating Loss: Operating loss widened to $36.2 million.
  • 🌍 Market Expansion: Focused on expanding sales territories in the U.S. and Europe.
  • 🔬 R&D Focus: Continued investment in research and development.
Major Announcements

CVRx announced the suspension of the BATwire clinical trial due to slow enrollment and the hiring of new leaders for sales, medical affairs, clinical, reimbursement, and human resources.
ALIGN TECHNOLOGY INC
Filing Date: 2024-08-02
TL;DR
  • 📈 Strong Revenue: $1.03 billion in Q2 2024, up from $1.00 billion in Q2 2023.
  • 💼 Legal Settlements: $31.1 million set aside for legal matters.
  • 🌍 Market Expansion: Focus on international growth.
  • 🌿 Sustainability: Committed to environmental initiatives.
Major Announcements

Significant announcements in 2024 include new partnerships in the healthcare sector and investments in renewable energy projects. These initiatives highlight Align's commitment to innovation and corporate social responsibility.
Paragon 28, Inc.
Filing Date: 2024-08-08
TL;DR
  • 📈 Strong Financials: Significant growth in revenue and market presence.
  • 🔧 Innovative Products: Launched nearly 80 product lines since 2011.
  • 🌍 Global Expansion: Products sold in 22 countries.
  • ♻️ Sustainability: Focus on developing advanced medical technologies.
Major Announcements

Significant announcements in 2023 included the acquisition of Additive Orthopaedics and Disior Oy, enhancing Paragon 28's capabilities in 3D printing and pre-operative planning software.
Embecta Corp.
Filing Date: 2024-08-09
TL;DR
  • 📉 Revenue Drop: Revenue decreased by 4.8% to $272.5 million.
  • 💰 Net Income: Net income slightly decreased to $14.7 million.
  • 🛠️ New Products: Submitted first 510(k) premarket filing to FDA.
  • 🌍 Global Presence: Operates in over 100 countries.
Major Announcements

Significant announcements in 2024 included the submission of the first 510(k) premarket filing to the FDA and amendments to the Transition Services Agreements and Logistics Services Agreements with BD.
ARTIVION, INC.
Filing Date: 2024-08-09
TL;DR
  • 📈 Revenue Growth: Revenue increased by 10% to $98 million in Q2 2024.
  • 💡 New Products: Launched new aortic stent grafts and surgical sealants.
  • 🌍 Market Expansion: Expanded presence in Europe, Middle East, and Africa.
  • 🌿 Sustainability Goals: Focused on improving tissue processing and reducing costs.
Major Announcements

Major announcements in 2024 include new partnerships in the healthcare sector and significant investments in improving tissue processing and sustainability. These initiatives underscore Artivion's commitment to innovation and corporate responsibility.
Neuraxis, INC
Filing Date: 2024-08-09
TL;DR
  • 📉 Revenue Drop: Sales decreased by 13.3% in the first half of 2024.
  • 💸 Net Loss: The company reported a net loss of $5 million for the first half of 2024.
  • 📈 Insurance Focus: Efforts are being made to gain more insurance coverage.
  • 🌍 Market Expansion: Targeting new indications like functional nausea and post-concussion syndrome.
Major Announcements

NeurAxis announced efforts to gain more insurance coverage for their IB-Stim device and new partnerships to expand their product indications. They also secured funding through convertible promissory notes.
UFP TECHNOLOGIES INC
Filing Date: 2024-08-09
TL;DR
  • 📈 Revenue Growth: Sales increased by 8.8% to $215.2 million.
  • 🩺 Medical Focus: Strong sales in robotic surgery and infection prevention products.
  • 🌍 Market Expansion: Increased presence in aerospace and defense markets.
  • ♻️ Sustainability: Committed to environmental initiatives and reducing carbon footprint.
Major Announcements

Significant announcements include the acquisition of Marble Medical and strategic investments in renewable energy projects. These moves highlight UFP Technologies' commitment to growth and sustainability.
CUTERA INC
Filing Date: 2024-08-09
TL;DR
  • 💵 Revenue Growth: Strong revenue performance in 2024.
  • 🛠 New Products: Launched innovative aesthetic systems.
  • 🌍 Market Expansion: Focus on emerging markets.
  • 🌿 Green Goals: Committed to sustainability.
Major Announcements

Cutera made significant announcements in 2024, including new partnerships with top dermatologists and beauty clinics. The company also announced investments in research and development to create next-generation aesthetic systems.
Envoy Medical, Inc.
Filing Date: 2024-08-12
TL;DR
  • 📉 Financial Losses: Net loss of $10.2 million for the first half of 2024.
  • 🔬 Focus on Innovation: Developing a new fully implanted cochlear implant.
  • 🏥 FDA Interactions: Working closely with FDA for product approvals.
  • 🌍 Market Expansion: Targeting growth in emerging markets.
Major Announcements

Significant announcements include the submission of an Investigational Device Exemption (IDE) application to the FDA for the Acclaim Cochlear Implant and securing additional funding through a term loan.
ELUTIA INC.
Filing Date: 2024-08-13
TL;DR
  • 📉 Financial Struggles: Net loss of $46.2 million for the first half of 2024.
  • 🩺 New Products: Launched EluPro, an antibacterial envelope device.
  • ⚖️ Legal Issues: Ongoing lawsuits related to FiberCel product.
  • 🌱 Sustainability: Focus on using more natural biological materials in products.
Major Announcements

Elutia announced the FDA approval of their EluPro product, a significant milestone for the company. They also disclosed ongoing legal proceedings related to their FiberCel product.
VAPOTHERM INC
Filing Date: 2024-08-12
TL;DR
  • 📈 Revenue Growth: Vapotherm saw an increase in revenue this year.
  • 💡 New Products: Launched new breathing support devices.
  • 🌍 Market Expansion: Focus on growing in new markets.
  • 🌿 Sustainability: Committed to reducing environmental impact.
Major Announcements

Significant announcements included new partnerships with healthcare providers and investments in research and development to innovate new products.
Catheter Precision, Inc.
Filing Date: 2024-08-14
TL;DR
  • 💰 Strong Revenue: Increased revenue and profits.
  • 🩺 Innovative Products: New heart treatment devices launched.
  • 🌍 Market Expansion: Growing presence in emerging markets.
  • 🌿 Sustainability: Focused on reducing environmental impact.
Major Announcements

Catheter Precision made several significant announcements in 2024. They introduced new partnerships with leading healthcare providers and announced investments in research and development to create even more advanced medical devices.
AETHLON MEDICAL INC
Filing Date: 2024-08-14
TL;DR
  • 🩺 Innovative Device: Hemopurifier treats cancer and viral infections.
  • 📉 Financial Struggles: Net loss of $2.57 million in Q2 2024.
  • 🌍 Global Trials: Clinical trials in the US, Australia, and India.
  • ♻️ Sustainability: Focus on reducing environmental impact.
Major Announcements

Aethlon Medical announced new clinical trials in Australia and India, as well as partnerships with research organizations to advance their Hemopurifier technology.
BioSig Technologies, Inc.
Filing Date: 2024-08-14
TL;DR
  • 📉 Revenue Drop: Revenue of $27,000 in the first half of 2024, down from $5,000 in 2023.
  • 🔄 Workforce Changes: Significant workforce reductions to cut costs.
  • 📉 Nasdaq Delisting: Delisted from Nasdaq due to non-compliance with listing rules.
  • 🔬 Product Focus: Continued focus on PURE EP System for heart treatments.
Major Announcements

Major announcements in 2024 included the intent to acquire the assets of Neuro-Kinesis Corporation and the delisting from Nasdaq. The company also announced workforce reductions to cut costs.
Electromed, Inc.
Filing Date: 2024-08-27
TL;DR
  • 📈 Revenue Growth: Revenue increased by 13.8% to $54.7 million in 2024.
  • 💡 New Products: Launched the SmartVest Clearway, a new version of their airway clearance system.
  • 🌍 Market Expansion: Continued growth in the U.S. homecare market.
  • 🌿 Sustainability: Focus on reducing healthcare costs through effective treatments.
Major Announcements

Electromed announced the launch of the SmartVest Clearway, an updated version of their airway clearance system with enhanced patient experience and modern design. The company also highlighted its focus on expanding its sales force and increasing market awareness of HFCWO therapy.
PRO DEX INC
Filing Date: 2024-09-05
TL;DR
  • 📉 Revenue Drop: Revenue decreased due to supply chain problems.
  • 🛠 New Products: Launched innovative surgical tools.
  • 🌍 Market Expansion: Focused on growing in new markets.
  • 🌿 Sustainability: Committed to eco-friendly practices.
Major Announcements

Pro-Dex announced a partnership with a leading hospital chain to develop custom surgical tools. They also revealed plans to invest in renewable energy projects.
psss. want annual reports you can read in 30 seconds?